INBRX-101/rhAAT-Fc
Ph1 INBRX-101
Phase 1 small_molecule completed
Quick answer
INBRX-101/rhAAT-Fc for Alpha-1 Antitrypsin Deficiency is a Phase 1 program (small_molecule) at Inhibrx Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Inhibrx Biosciences
- Indication
- Alpha-1 Antitrypsin Deficiency
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed